Hopkinson Craig C., EVP R&D, Chief Medical Officer at Alkermes plc., sold $320K of ALKS
This page documents an SEC Form 4 insider trading disclosure for $ALKS securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Hopkinson Craig C. |
|---|---|
| Title | EVP R&D, Chief Medical Officer |
| Company | Alkermes plc. |
| Ticker | ALKS |
| Transaction Type | Sale |
| Transaction Date | 2026-04-01 |
| Shares Traded | 9,000 |
| Price Per Share | $35.5116 |
| Total Value | $320K |
| Filed Date | 2026-04-01 |
| Accession Number | 0001520262-26-000065 |
Ownership Context
| Shares Owned After Transaction | 85,389 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001520262-26-000065
Other Insider Trades — ALKS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Jackson Blair Curtis | President & CEO, Alkermes plc, Director | traded | — | 2026-08-05 |
| Jackson Blair Curtis | President & CEO, Alkermes plc, Director | traded | — | 2026-08-05 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | sold | $437K | 2026-08-03 |
| snyderman nancy lynn MD | Director | sold | $2.2M | 2026-08-03 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | traded | $2K | 2026-08-03 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | traded | $120K | 2026-08-03 |
| snyderman nancy lynn MD | Director | traded | $1.3M | 2026-08-03 |
| snyderman nancy lynn MD | Director | traded | $772K | 2026-08-03 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | sold | $99K | 2026-08-03 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | sold | $110K | 2026-07-06 |
Other Trades by Hopkinson Craig C.
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ALKS | Alkermes plc. | traded | $2K | 2026-08-03 |
| ALKS | Alkermes plc. | sold | $437K | 2026-08-03 |
| ALKS | Alkermes plc. | traded | $120K | 2026-08-03 |
| ALKS | Alkermes plc. | traded | $97K | 2026-07-01 |
| ALKS | Alkermes plc. | sold | $427K | 2026-07-01 |
| ALKS | Alkermes plc. | sold | $36K | 2026-07-01 |
| ALKS | Alkermes plc. | traded | $97K | 2026-06-01 |
| ALKS | Alkermes plc. | sold | $375K | 2026-06-01 |
| ALKS | Alkermes plc. | sold | $301K | 2026-05-01 |
| ALKS | Alkermes plc. | traded | $97K | 2026-05-01 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ALKS — Alkermes plc. →
Whisper Score — ALKS
Track ALKS insider activity in real time on The Wire →
Get alerts when Hopkinson Craig C. files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:40 UTC